Targeting pro-resolution pathways to combat chronic inflammation in COPD
Open Access
- 1 November 2014
- journal article
- review article
- Vol. 6 (11) , 1548-1556-1556
Abstract
Targeting pro-resolution pathways to combat chronic inflammation in COPDKeywords
This publication has 81 references indexed in Scilit:
- Serum Amyloid A Promotes Lung Neutrophilia by Increasing IL-17A Levels in the Mucosa and γδ T CellsAmerican Journal of Respiratory and Critical Care Medicine, 2013
- New insights into the immunology of chronic obstructive pulmonary diseaseThe Lancet, 2011
- FPR2/ALX receptor expression and internalization are critical for lipoxin A 4 and annexin‐derived peptide‐stimulated phagocytosisThe FASEB Journal, 2010
- 15-Epi-lipoxin A4 Inhibits Myeloperoxidase Signaling and Enhances Resolution of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2009
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) FamilyPharmacological Reviews, 2009
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): A jungle of cell-cell interactions or a therapeutic opportunity?Prostaglandins, 1997
- Bacterial Infection in Chronic Obstructive Pulmonary Disease. A Study of Stable and Exacerbated Outpatients Using the Protected Specimen BrushAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet‐activating factor and N‐formyl‐L‐methionyl‐L‐leucyl‐L‐phenylalanineAllergy, 1994